Most therapeutic peptides are administered via injectioneither subcutaneously (just under the skin) or intramuscularly
The SURPASS program demonstrated HbA1c reductions of 2.0-2.3% at the 15mg dose, with many participants achieving HbA1c below 5.7% (the threshold for normal blood sugar)
In addition, the xCT activity of mice treated with high-dose LA was enhanced compared with mice injected with FA, but there was no significant increase in activity compared with mice treated with low-dose LA
Unlike benzodiazepines or other sedatives, it doesn't appear to create tolerance requiring escalating doses or produce withdrawal symptoms upon cessation
2 Experimental 2.1 Materials and apparatus Cetyltrimethylammonium bromide (98%, CTAB), triethanolamine (TEA), dimethylformamide (DMF), dimethyl sulfoxide (DMSO), hydrochloride acid (HCl), ethanol, glutathione (GSH), N-hydroxysuccinimide, tetraethyl ortho silicate (98%, TEOS), N, N-dicyclohexyl carbodiimide (DCC), mercapto propyl trimethoxy silane (MPS), dithiothreitol (DTT), citric acid, and phosphate buffer saline (PBS, pH 7.4) were prepared from Merck Company (Darmstadt, Germany)
